kidney cancer renal cell cancer
Conditions
Interventions
Biomarkers
Body composition
Lifestyle
Renal cell carcinoma
Sponsors
Radboud Universitair Medisch Centrum
Eligibility
Age
18 Years to 64 Years
Inclusion criteria
Inclusion criteria: - Stage I-III RCC, diagnosed from 2017 - Aged between 18 and 75 years at diagnosis - Able to communicate in Dutch, to read and understand the patient information and informed consent form - Able to fill out questionnaires, and to visit the hospital to donate blood samples
Exclusion criteria
Exclusion criteria: Patients diagnosed with another type of cancer in the 5 years before RCC diagnosis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The main study endpoints are cross-sectional area and mean radiodensity of SM, VAT, and APF at baseline. The main study parameters are patient and tumour characteristics, dietary and physical activity habits, and circulating concentrations of biomarkers (in total 18 parameters, e.g. age, sex, tumour stage, and energy intake). | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary study endpoints are cross-sectional areas and mean radiodensity of SAT, IMAT, and TAT at baseline, cross-sectional areas and mean radiodensity of all body composition features at follow-up, and changes in cross-sectional areas and mean radiodensity of all body composition features per year. Secondary study parameters are other patient and tumour characteristics, dietary and physical activity habits, and circulating concentrations of biomarkers. | — |
Countries
The Netherlands
Outcome results
None listed